Investors > Financial Reports and Presentations

Acacia Pharma KOL Webinar: Hospital User Experience with Barhemsys® and Byfavo®

Interim Results for the Six Months ended 30 June 2021 - Barhemsys® and Byfavo® Launches Continue to Achieve Strong Hospital Formulary Adoption

Acacia Pharma Group plc Mid-Year Presentation of Results for the Six Months ended 30 June 2021

Download and listen to the Mid-Year results audiocast

Acacia Pharma Corporate Presentation – Jefferies Healthcare Conference, June 2021

Acacia Pharma Group plc Annual Report and Financial Statements for the Year ended 31 December 2020

Results for the Year Ended 31 Dec 2020

Presentation of Results for the Year Ended 31 Dec 2020

Watch the webcast

Acacia Pharma Corporate Presentation – Degroof Petercam Virtual Healthcare Conference, January 2021

Acacia Pharma Corporate Presentation September 2020

Interim Results for the Six Months ended 30 June 2020

US Approval of BYFAVO conference call presentation 

Acacia Pharma Group plc Annual Report and Financial Statements for the year ended 31 December 2019

Results for the Year Ended 31 December 2019

BARHEMSYS® approved by US FDA - 27 February 2020 

Cosmo Agreement - Conference Call Presentation 10 Jan 2020 

Interim Results 2019 Presentation

Interim Results for the Six Months ended 30 June 2019

Notice of 2019 AGM

2019 AGM Form of Proxy

Annual Report and Consolidated Financial Statements for the year ended 31 December 2018

Results for the year ended 31 December 2018

Unaudited Results for the nine months to 30 September 2018

Interim results for the First Half Year 2018

Annual Report and Consolidated Financial Statements for the year ended 31 December 2017